AGL · NYSE · CIK 0001831097

agilon health, inc.

agilon health, inc.’s most recent SEC filing in our snapshot is a Form 4 filed on Aug 18, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $5.9B and net income of -$391.3M, according to its XBRL data on EDGAR. Its EDGAR record lists 27 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$5.9B
Net income, FY2025
-$391.3M
Form 4 filings on record, past 12 months
27

Company overview

Legal name (as filed)
agilon health, inc.
Ticker
AGL
SEC Central Index Key (CIK)
0001831097
Business address
WESTERVILLE, OH
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2178 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from agilon health, inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$1.5BFY2021$2.4BFY2022$4.3BFY2023$6.1BFY2024$5.9BFY2025
Net income
-$406.5MFY2021-$106.6MFY2022-$262.6MFY2023-$260.2MFY2024-$391.3MFY2025
AGL annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$1.5B$2.4B$4.3B$6.1B$5.9B
Net income-$406.5M-$106.6M-$262.6M-$260.2M-$391.3M
Diluted EPS—————
Total assets$1.6B$1.7B$1.7B$1.7B$1.3B
Cash and equivalents$1.0B$465.3M$107.6M$188.2M$173.7M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

AGL latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 25, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 5, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 5, 20268-KResults of operations· period Aug 5, 2026Document · Index
Apr 22, 2026DEF 14ADefinitive proxy statement· period Jun 2, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about agilon health, inc., by form type:

4 ×228-K ×7SCHEDULE 13G/A ×210-Q ×2SCHEDULE 13G ×2DEFA14A ×23 ×1ARS ×1DEF 14A ×1
AGL recent filings
FiledFormWhat it isOriginal
Aug 18, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 16, 2026Document · Index
Aug 12, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 11, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 5, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 5, 20268-KResults of operations· period Aug 5, 2026Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 1, 2026Document · Index
Jul 22, 20268-KDirector or officer change· period Jul 17, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jun 5, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 2, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 2, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 2, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 2, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 2, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 2, 2026Document · Index
Jun 3, 20268-KShareholder vote results· period Jun 2, 2026Document · Index
May 27, 20264Statement of changes in beneficial ownership (insider trade)· period May 24, 2026Document · Index
May 14, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
May 13, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20263Initial statement of beneficial ownership· period May 7, 2026Document · Index
May 6, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 6, 20268-KResults of operations· period May 6, 2026Document · Index
Apr 27, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Apr 27, 20268-KDirector or officer change; Regulation FD disclosure· period Apr 24, 2026Document · Index
Apr 23, 2026ARSARS· period Dec 31, 2025Document · Index
Apr 23, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Apr 22, 2026DEF 14ADefinitive proxy statement· period Jun 2, 2026Document · Index
Apr 16, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 14, 2026Document · Index
Apr 16, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 14, 2026Document · Index
Apr 16, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 14, 2026Document · Index
Apr 16, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 14, 2026Document · Index
Apr 3, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 3, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 3, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 3, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 3, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Mar 30, 20268-KChange to shareholder rights; Charter, bylaws or fiscal year change· period Mar 30, 2026Document · Index
Mar 18, 20268-KShareholder vote results; Other events· period Mar 17, 2026Document · Index
Mar 11, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 9, 2026Document · Index

Insider filing activity

27 Form 4 filings appear in agilon health, inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Services-Misc Health & Allied Services, NEC

All 6 companies in Services-Misc Health & Allied Services, NEC· Companies headquartered in Ohio

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001831097 and XBRL company facts. agilon health, inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.